Navigation Links
Motor Neurone Disease Association study identifies MND biomarker
Date:11/4/2010

A study funded by the Motor Neurone Disease (MND) Association, in collaboration with the Medical Research Council (MRC), has identified a common signature of nerve damage in the brains of MND patients.

The study's exciting findings have been published in the prestigious journal Neurology (2 November 2010). These are the first results to be published from the ongoing Oxford Study for Biomarkers in MND/ALS (BioMOx).

MND research is being held back by the lack of an early diagnostic test and predictable markers of the progression of the disease biomarkers. Patients still wait too long for a certain diagnosis of MND and clinical trials are hampered by lengthy study times and variability of the disease between people living with MND. If MND biomarkers can be identified then they could dramatically improve the speed and accuracy with which MND can be diagnosed, and how future treatments are assessed.

This study used an advanced magnetic resonance imaging (MRI) technique, to look for areas of the brain that are universally damaged in patients with MND as compared to healthy controls. From this, Dr Martin Turner and colleagues at the University of Oxford found a unique similarity of nerve damage in a region of the brain that connects the motor neurones to the brain as well as damage to a region that acts as a connection between the left and right sides of the brain known as the 'corpus callosum'.

Talking about the study findings, Dr Martin Turner says: "The finding of a common pattern of nerve pathway damage in a varied group of MND patients holds the promise of a much needed biomarker.

"This study confirms the ability of advanced MRI techniques to sensitively detect nerve damage in a wide range of people living with MND. It builds on a decade of international work, and shows that MRI is now a frontrunner in the quest to generate biomarkers of disease activity in MND."

Dr Brian Dickie, director of research development at the Motor Neurone Disease Association, adds: "MRI scanning provides an exciting 'window on the brain', allowing researchers to link the changes occurring in the central nervous system with the 'real world' symptoms of motor neurone disease. Understanding these changing events is going to be central to the development of future treatments."

Dr Martin Turner was awarded the Association's first joint-funded MRC/MND Association Lady Edith Wolfson Clinical Research Fellowship in 2008 for his proposed BioMOx study.

The BioMOx study aims to develop a biomarker for MND by following changes in the brain, in the blood and in spinal cord fluid of people living with MND, every six months. People living with MND have made, and continue to make, a significant contribution in giving their time and effort to make this research project possible.

Dr Dickie continues: "The BioMOx study is one of the largest biomarker studies for motor neurone disease in the world. It's very encouraging to hear the first exciting results emerging from this four-year initiative."

The Lady Edith Wolfson Fellowships aim to attract and develop outstanding young clinicians in MND research, in order to create future scientific leaders in the field. Good researchers are fundamental to good research and developing the MND research workforce is a key element of the Association's research strategy.

The fellowships are an exciting development in MND research as they are allowing the MND Association to attract the best young clinicians, help develop their scientific expertise and place them at the heart of translating knowledge from the lab to the MND clinic.


'/>"/>

Contact: Louise Coxon
louise.coxon@mndassociation.org
01-604-611-843
Motor Neurone Disease Association
Source:Eurekalert

Related biology news :

1. Motorola Introduces Mobile Biometric Identification for Handheld Computers
2. SAFRAN to Acquire Motorolas Biometrics Business
3. Motor nerve targeting to limb muscles is controlled by ephrin proteins
4. Biologists learn structure, mechanism of powerful molecular motor in virus
5. Microbot motors fit to swim human arteries
6. UCLA stem cells scientists make electrically active motor neurons from iPS cells
7. First neuroimaging study examining motor execution in children with autism reveals new insights
8. Researchers design first model motor nerve system thats insulated and organized like the human body
9. Atomic-level snapshot catches protein motor in action
10. New study possibly links cognitive and motor delays with flat head syndrome in young babies
11. Lifes smallest motor, cargo carrier of the cells, moves like a seesaw
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2016)... 2016  Extenua Inc., a pioneering developer of ... and access of ubiquitous on-premise and cloud storage, today ... Cyber.  ... C4ISR and Cyber initiatives in support of National ... technology solutions," said Steve Visconti , Extenua ...
(Date:1/11/2016)... 2016 Synaptics Incorporated (NASDAQ: SYNA ), ... that its ClearPad ® TouchView ™ 4300 ... separate categories in the 8 th Annual Mobile ... Breakthrough. The Synaptics ® TDDI solution enables faster ... thinner devices, brighter displays and borderless designs. ...
(Date:1/7/2016)... , Jan. 7, 2016 This BCC Research ... for biometric technologies and devices, identifying newer markets and ... various types of biometric devices. Includes forecast from 2015 ... Identify newer markets and explore the expansion of the ... Examine each type of biometric technology, determine its current ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... ... February 04, 2016 , ... Morf ... today announced an interactive FDA compliance training course, Writing Effective ... Professional Society) accredited interactive course on Morf Playbook—now conveniently available on smartphones and ...
(Date:2/4/2016)... ... February 04, 2016 , ... ... and triple quad LC-MS, host live demos and poster sessions, and present on ... exhibition. The conference takes place March 6 to 10 at the Georgia World ...
(Date:2/4/2016)... MONMOUTH JUNCTION, N.J. , Feb. 4, 2016 ... critical care immunotherapy leader commercializing its flagship CytoSorb® ... and cardiac surgery patients around the world, announced ... PhD, will present at the Source Capital Group,s ... overview and update on the company.  ...
(Date:2/4/2016)... 4, 2016 ContraVir Pharmaceuticals, Inc. (NASDAQ: ... and commercialization of targeted antiviral therapies, announced today that ... 2016, to be held February 8-9, 2016, at the ... Disruptive Growth & Healthcare Conference, taking place in ... James Sapirstein , Chief Executive Officer of ...
Breaking Biology Technology: